To include your compound in the COVID-19 Resource Center, submit it here.

Trio of follow-ons lift 2019 tally of deals

December’s rush of follow-ons has continued with Rocket, Constellation and Marinus all pricing follow-on offerings since Tuesday’s close to raise more than $340 million. But cash raised via follow-ons continues to lag behind last year's numbers.

The latest financings bring this year’s tally to about $21 billion. In 2018, biotechs raised nearly $27 billion in 258 follow-ons, up from $22.6

Read the full 604 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE